Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Neumora Therapeutics (NMRA) News Today

→ Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad)
Free NMRA Stock Alerts
$9.67
+0.04 (+0.42%)
(As of 05/17/2024 08:54 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
May 14, 2024 | globenewswire.com
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
May 12, 2024 | americanbankingnews.com
Neumora Therapeutics (NASDAQ:NMRA) Shares Down 7.5%
May 11, 2024 | americanbankingnews.com
Neumora Therapeutics, Inc. to Post Q3 2024 Earnings of ($0.37) Per Share, William Blair Forecasts (NASDAQ:NMRA)
May 10, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Trading Down 7.5%
Neumora Therapeutics (NASDAQ:NMRA) Shares Down 7.5%
May 10, 2024 | marketbeat.com
William Blair Brokers Lower Earnings Estimates for Neumora Therapeutics, Inc. (NASDAQ:NMRA)
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) - Stock analysts at William Blair lowered their Q3 2024 EPS estimates for Neumora Therapeutics in a research report issued on Tuesday, May 7th. William Blair analyst M. Minter now expects that the company will earn ($0.37) per share for the q
May 8, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Posts Earnings Results, Hits Expectations
Neumora Therapeutics (NASDAQ:NMRA - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.34) EPS for the quarter, hitting the consensus estimate of ($0.34).
May 8, 2024 | finanznachrichten.de
Neumora Therapeutics, Inc.: Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 7, 2024 | investorplace.com
NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q1 2024
May 7, 2024 | globenewswire.com
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 6, 2024 | finance.yahoo.com
Neumora Therapeutics to Participate in Upcoming Conferences in May
May 2, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Sees Strong Trading Volume
Neumora Therapeutics (NASDAQ:NMRA) Sees Large Volume Increase
April 29, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Stock Price Up 6.2%
Neumora Therapeutics (NASDAQ:NMRA) Trading 6.2% Higher
April 27, 2024 | msn.com
Parkinson’s UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson’s drug
April 27, 2024 | marketbeat.com
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) have been given an average rating of "Moderate Buy" by the seven research firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and six have issued a buy
April 25, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Sets New 52-Week Low at $8.98
Neumora Therapeutics (NASDAQ:NMRA) Hits New 1-Year Low at $8.98
April 24, 2024 | finance.yahoo.com
We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely
April 19, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Trading Down 4.6%
Neumora Therapeutics (NASDAQ:NMRA) Trading Down 4.6%
April 18, 2024 | finance.yahoo.com
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
April 17, 2024 | msn.com
Neumora Therapeutics (NMRA) Price Target Increased by 6.99% to 25.76
April 17, 2024 | nasdaq.com
Neumora Therapeutics Becomes Oversold (NMRA)
April 16, 2024 | finanznachrichten.de
Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
April 15, 2024 | bizjournals.com
FDA pauses Watertown biotech’s schizophrenia trial
April 15, 2024 | finance.yahoo.com
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
April 15, 2024 | finance.yahoo.com
Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
April 15, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down to $13.56
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down to $13.56
April 15, 2024 | marketwatch.com
Neumora Shares Slide Premarket as FDA Puts Early Study of Schizophrenia Drug on Hold
April 15, 2024 | markets.businessinsider.com
FDA Places Clinical Hold On Neumora's Phase 1 Study Of NMRA-266; Stock Tanks In Pre-Market
April 15, 2024 | investorplace.com
Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?
April 15, 2024 | globenewswire.com
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
April 12, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Given Outperform Rating at William Blair
William Blair reiterated an "outperform" rating on shares of Neumora Therapeutics in a research report on Friday.
April 11, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Trading Down 4.4%
Neumora Therapeutics (NASDAQ:NMRA) Shares Down 4.4%
April 2, 2024 | marketbeat.com
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have a
April 1, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Stock Price Up 4.3%
Neumora Therapeutics (NASDAQ:NMRA) Trading 4.3% Higher
March 28, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Receives "Outperform" Rating from Royal Bank of Canada
Royal Bank of Canada reiterated an "outperform" rating and issued a $31.00 target price on shares of Neumora Therapeutics in a report on Thursday.
March 25, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down to $13.21
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down to $13.21
March 22, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Trading Down 6.9%
Neumora Therapeutics (NASDAQ:NMRA) Stock Price Down 6.9%
March 18, 2024 | marketbeat.com
JPMorgan Chase & Co. Increases Neumora Therapeutics (NASDAQ:NMRA) Price Target to $22.00
JPMorgan Chase & Co. upped their price target on shares of Neumora Therapeutics from $20.00 to $22.00 and gave the stock an "overweight" rating in a report on Monday.
March 16, 2024 | finance.yahoo.com
NMRA Apr 2024 17.500 put
March 14, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Trading 3.6% Higher
Neumora Therapeutics (NASDAQ:NMRA) Stock Price Up 3.6%
March 14, 2024 | finance.yahoo.com
institutional investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) must be disappointed after last week's 20% drop
March 13, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down to $17.35
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Down to $17.35
March 13, 2024 | globenewswire.com
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days
March 8, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS
Neumora Therapeutics (NASDAQ:NMRA - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.71) EPS for the quarter, topping analysts' consensus estimates of ($0.76) by $0.05.
March 8, 2024 | marketbeat.com
Neumora Therapeutics (NASDAQ:NMRA) Sets New 12-Month High on Earnings Beat
Neumora Therapeutics (NASDAQ:NMRA) Reaches New 52-Week High Following Better-Than-Expected Earnings
March 8, 2024 | marketbeat.com
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Recommendation of "Moderate Buy" from Analysts
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and six have issued a buy ra
March 7, 2024 | investorplace.com
NMRA Stock Earnings: Neumora Therapeutics Misses EPS for Q4 2023
March 7, 2024 | finanznachrichten.de
Neumora Therapeutics, Inc.: Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 7, 2024 | globenewswire.com
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 28, 2024 | marketbeat.com
Fmr LLC Acquires New Shares in Neumora Therapeutics, Inc. (NASDAQ:NMRA)
Fmr LLC purchased a new stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 5,624,353 shares of the company's stock, valued at ap
February 15, 2024 | finance.yahoo.com
NMRA Feb 2024 12.500 call
Get Neumora Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRA and its competitors with MarketBeat's FREE daily newsletter.

4 Cryptos BETTER than Bitcoin (Ad)

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024

NMRA Media Mentions By Week

NMRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NMRA
News Sentiment
▼
0.00

0.42
▲
Average
Medical
News Sentiment

NMRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NMRA Articles
This Week
▼
1

2
▲
NMRA Articles
Average Week

Get Neumora Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:NMRA) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Next President (Not Trump. Not Biden.)
The Freeport Society
Urgent Nvidia Warning
Altimetry
Elon’s New Device is About to Shock the World
InvestorPlace
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders